Vital Pursuit launches protein-packed Max Pro Pizzas
Nestlé’s Vital Pursuit is transforming frozen pizza with its Max Pro line, which launches this January and features unmatched protein and fiber content.
Nestlé’s Vital Pursuit is transforming frozen pizza with its Max Pro line, which launches this January and features unmatched protein and fiber content.
The judge rejected Kroger and Albertsons' proposed store divestiture plan, calling it insufficient to maintain competition.
A recent analysis reveals that Medicare Part D plans increasingly restrict generic drugs to higher-cost tiers.
Founders' Innovation Day empowered emerging brands with education, strategies, and networking to drive growth and success in retail.
Over two hundred people attended Founders' Innovation Day, hosted by retailmediaIQ and ECRM in NYC.
The groups say that bipartisan recognition of PBMs’ detrimental practices is widespread.
MMR proudly awards retail icon Donna Tweeten with a Lifetime Achievement Award.
AI, now widely used across health care, poses unique challenges.
Brian Thompson, CEO of UnitedHealthcare, was killed in a shooting in Midtown Manhattan on Wednesday morning in what authorities believe was a targeted attack.
Tim Barry, the co-founder and CEO of VillageMD, has left the company.
Haleon has appointed Joe Sta-Romana as Chief Customer Officer for its U.S. operations to lead customer-focused strategies, strengthen retail partnerships, and drive market growth and innovation.
retailmediaIQ, publisher of Chain Drug Review and Mass Market Retailers, has opened nominations for MMR’s prestigious Women of Influence event, which honors leaders whose innovative contributions have shaped the future of retail.
GlobalData warns that President-elect Trump's proposed tariffs could raise prices and disrupt access to 75% of U.S. medical devices.
BridgeBio Pharma has received FDA approval for a new drug for a rare heart disease after very promising trials.
Governor Kathy Hochul announced new regulations to govern Pharmacy Benefit Managers in New York. They aim to reduce prescription drug costs, increase transparency, and support small, independent pharmacies.
Johnson & Johnson has submitted an FDA application for the first subcutaneous IL-23 inhibitor for ulcerative colitis. This drug could offer patients a groundbreaking at-home treatment option.